Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling

Journal of Cellular Biochemistry

Volumn 108, Issue 2, 2009, Pages 388-399

  Bhargavan, Biju ^a   Gautam, Abnish Kumar ^a   Singh, Divya ^a,b   Kumar, Amit ^a   Chaurasia, Sumit ^a   Tyagi, Abdul Malik ^a   Yadav, Dinesh Kumar ^a   Mishra, Jay Sharan ^a   Singh, Amar Bahadur ^a   Sanyal, Sabyasachi ^a   Goel, Atul ^a   Maurya, Rakesh ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b NONE   (India)

Author keywords

Apoptosis; Cajanin; Isoformononetin; MAPK signaling; Osteogenic; Peak bone mass

Indexed keywords

CAJANIN; ISOFLAVONE DERIVATIVE; ISOFORMONONETIN; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DENSITY; BONE MASS; BONE STRENGTH; BUTEA; BUTEA MONOSPERMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGING; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BONE AND BONES; BONE DENSITY; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIETHYLSTILBESTROL; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GENISTEIN; ISOFLAVONES; MAP KINASE SIGNALING SYSTEM; OSTEOBLASTS; OSTEOGENESIS; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

BUTEA MONOSPERMA; RATTUS;

EID: 70349246398     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22264     Document Type: Article

References (33)

1. Anderson JJ, Garner SC. 1998. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12:543-557.
2. Bass RJ. 1976. Synthesis of chromones by cyclization of 2-hydroxyphenyl ketones with boron trifluoride-diethyl ether and methanesulphonyl chloride. J Chem Soc Chem Commun 2:78-79.
3. Choi SY, Ha TY, Ahn JY, Kim SR, Kang KS, Hwang IK, Kim S. 2008. Estrogenic activities of isoflavones and flavones and their structure-activity relationships. Planta Med 74:25-32. (Pubitemid 351251379)
4. Chrzan BG, Bradford PG. 2007. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines. Mol Nutr Food Res 51:171-177.
5. De Wilde A, Lieberherr M, Colin C, Pointillart A. 2004. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. J Cell Physiol 200:253-262. (Pubitemid 38885706)
6. Farmakalidis E, Hathcock JN, Murphy PA. 1985. Oestrogenic potency of genistin and daidzin in mice. Food Chem Toxicol 23:741-745. (Pubitemid 15233661)
7. Fujioka M, Sudo Y, Okumura M, Wu J, Uehara M, Takeda K, Hosokawa Y, Yamada K, Ikegami S, Ishimi Y. 2007. Differential effects of isoflavones on bone formation in growing male and female mice. Metabolism 56:1142-1148.
8. Geller SE, Studee L. 2006. Soy and red clover for mid-life and aging. Climacteric 9:245-263. (Pubitemid 44147845)
9. Gregory CA, Gunn WG, Peister A, Prockop DJ. 2004. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77-84. (Pubitemid 38596903)
10. Hara K, Kobayashi M, Akiyama Y. 2002. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 31:575-581. (Pubitemid 35449699)
11. Hopert AC, Beyer A, Frank K, Strunck E, Wunsche W, Vollmer G. 1998. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ Health Perspect 106:581-586. (Pubitemid 28495434)
12. Ishimi Y, Yoshida M, Wakimoto S, Wu J, Chiba H, Wang X, Takeda K, Miyaura C. 2002. Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice. Bone 31:180-185. (Pubitemid 34754445)
13. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A. 1997. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970. (Pubitemid 27278673)
14. Kritz-Silverstein D, Goodman-Gruen DL. 2002. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med 11:69-78. (Pubitemid 34196286)
15. Matsumura A, Ghosh A, Pope GS, Darbre PD. 2005. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94:431-443. (Pubitemid 40616404)
16. Maurya R, Yadav DK, Singh G, Bhargavan B, Narayana Murthy PS, Sahai M, Singh MM. 2009. Osteogenic activity of constituents from Butea monosperma. Bioorg Med Chem Lett 19:610-613.
17. Mei J, Yeung SS, Kung AW. 2001. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217-5221. (Pubitemid 33070238)
18. Miller CP, Collini MD, Harris HA. 2003. Constrained phytoestrogens and analogues as ERb selective ligands. Bioorg Med Chem Lett 13:2399-2403.
19. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y. 2002. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 25:48-52.
20. Orwoll ES, Belknap JK, Klein RF. 2001. Gender specificity in the genetic determinants of peak bone mass. J Bone Miner Res 16:1962-1971.
21. Peterson TG, Ji GP, Kirk M, Coward L, Falany CN, Barnes S. 1998. Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. Am J Clin Nutr 68:1505S-1511S. (Pubitemid 28550938)
22. Phrakonkham P, Chevalier J, Desmetz C, Pinnert MF, Berges R, Jover E, Davicco MJ, Bennetau-Pelissero C, Coxam V, Artur Y, Canivenc-Lavier MC. 2007. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol Appl Pharmacol 224:105-115. (Pubitemid 47494513)
23. Setchell KD, Lydeking-Olsen E. 2003. Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S-609S. (Pubitemid 40012554)
24. Shao ZM, Alpaugh ML, Fontana JA, Barsky SH. 1998. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69:44-54. (Pubitemid 28099921)
25. Sharan K, Siddiqui JA, Swarnkar G, Maurya R, Chattopadhyay N. 2009. Role of phytochemicals in the prevention of menopausal bone loss: Evidence from in vitro and in vivo, human interventional and pharmacokinetic studies. Curr Med Chem 16:1138-1157.
26. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. 2001. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97:109-115. (Pubitemid 32057167)
27. Song TT, Hendrich S, Murphy PA. 1999. Estrogenic activity of glycitein, a soy isoflavone. J Agric Food Chem 47:1607-1610. (Pubitemid 29217165)
28. Sowers MF. 2000. Lower peak bone mass and its decline. Baillieres Best Pract Res Clin Endocrinol Metab 14:317-329. (Pubitemid 30826999)
29. Srivastava SR, Keshri G, Bhargavan B, Singh C, Singh MM. 2007. Pregnancy interceptive activity of the roots of Calotropis gigantea Linn in rats. Contraception 75:318-322. (Pubitemid 46385921)
30. Trivedi R, Kumar S, Kumar A, Siddiqui JA, Swarnkar G, Gupta V, Kendurker A, Dwivedi AK, Romero JR, Chattopadhyay N. 2008. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 289:85-93.
31. Umehara K, Nemoto K, Kimijima K, Matsushita A, Terada E, Monthakantirat O, De-Eknamkul W, Miyase T, Warashina T, Degawa M, Noguchi H. 2008. Estrogenic constituents of the heartwood of Dalbergia parviflora. Phytochemistry 69:546-552.
32. Yamaguchi M, Sugimoto E. 2000. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase. Mol Cell Biochem 214:97-102. (Pubitemid 32010329)
33. Yoshida H, Teramoto T, Ikeda K, Yamori Y. 2001. Glycitein effect on suppressing the proliferation and stimulating the differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem 65:1211-1213. (Pubitemid 33665983)